CMXC insider transaction filings
Cell MedX Corp. — 5 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-01-10. Screen CMXC transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for CMXC between 2026-06-23 and 2026-09-21. The table below lists the most recent filings on record.
Recent Form 4 filings — Cell MedX Corp.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-01-10 | 4 | Jeffs David — Chief Executive Officer, Director, 10% owner | Grant/award (A): 73,959,726 @ $0.01 · Purchase (P): 7,500,000 @ $0.01 · Purchase (P): 7,500,000 @ $0.01 | EDGAR |
| 2024-01-09 | 4 | Vahabzadeh Amir — Director, 10% owner | Grant/award (A): 61,755,148 @ $0.01 | EDGAR |
| 2024-01-09 | 4 | Yaretz Dwayne — Director | Grant/award (A): 1,214,285 @ $0.01 | EDGAR |
| 2024-01-09 | 4 | daCosta Joao — Director | Grant/award (A): 531,687 @ $0.01 | EDGAR |
| 2024-01-09 | 4 | JEFFS RICHARD — 10% owner | Purchase (P): 14,372,285 @ $0.01 | EDGAR |
Recent 8-K events — Cell MedX Corp.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-02 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-02-27 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-05 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-04-04 | 8-K | 3.02 — Unregistered Sales of Equity Securities 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-28 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CMXC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →